Coland Holdings Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Coland Holdings Limited with three other
companies in this sector in CHINA :
Zhejiang Shengda Bio-pharm Co Ltd
sales of 519.15 million Chinese Renmimbi [US$72.81 million]
of which 49%
Zhejiang Shapuaisi Pharmaceutical Co Ltd
(515.91 million Chinese Renmimbi [US$72.36 million]
of which 45%
was Eye drops), and
Guangdong Jiaying Pharmaceutical Co., Limited
(500.50 million Chinese Renmimbi [US$70.20 million]
of which 99%
was Pharmaceuticals Industry).
Coland Holdings Limited reported sales of 484.00 million Chinese Renmimbi (US$67.88 million)
December of 2019.
increase of 3.2%
versus 2018, when the company's sales were 468.95 million Chinese Renmimbi.
Despite this increase, sales are still
below the level achieved in 2017, when Coland Holdings Limited
reported sales of 586.59 million Chinese Renmimbi.
The sales level in 2019 was fairly close to the level five years ago: in 2014, Coland Holdings Limited had sales
of 447.89 million Chinese Renmimbi.